Vasomotor symptoms closely associated with low BMD in postmenopausal women

Importantly, the conclusions of this study remained consistent even after accounting for factors such as the severity of VMS, age and study design. Furthermore, the association between VMS and low BMD persisted when the analysis was limited to the studies that excluded the use of menopausal hormone therapy by indicating the robustness of the findings.

Overall, the findings of this study have significant outcomes for the management of the postmenopausal health in women. While VMS may not directly increase the fracture risk, their association with reduced BMD illuminates the importance of addressing these symptoms early on to reduce the potential long-term effects on bone health.

These studies continue to look deeper into the complex interplay between menopause-related symptoms and the various aspects of women's health that contribute to the valuable evidence which can guide the clinical practice and improve the quality of life for postmenopausal women. The findings underline the need for holistic approaches to menopausal care that prioritize both symptomatic management and the preservation of bone health.

Source:

Anagnostis, P., Lallas, K., Pappa, A., Avgeris, G., Beta, K., Damakis, D., Fountoukidou, E., Zidrou, M., Lambrinoudaki, I., & Goulis, D. G. (2024). The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies. In Osteoporosis International. Springer Science and Business Media LLC. https://doi.org/10.1007/s00198-024-07075-8